Top Markets
Coin of the day
LexaGene Holdings Inc. LexaGene Holdings Inc.

LexaGene Holdings Inc.

0V43
Rank in Stocks #30874
LexaGene Holdings Inc. is a biotechnology firm specializing in the invention,... LexaGene Holdings Inc. is a biotechnology firm specializing in the invention, refinement, and commercialization of systems for detecting pathogens. The company's flagship product, MiQLab, is an automated pathogen identification system engineered to revolutionize diagnostics in diverse sectors, including animal and human healthcare, food and water quality assurance, and other life science applications. This advanced platform functions directly at the location of sample collection, providing remarkable simplicity, heightened sensitivity, and extensive pathogen screening capabilities. Founded in 2007, LexaGene is headquartered in Beverly, Massachusetts.
Share Price
$0.1174299
Last synced: 2023-02-22
Market Cap
$15.21M
Change (1 day)
-0.92%
Change (1 year)
0.00%
Country
US
Trade LexaGene Holdings Inc. (0V43)

Category

Operating Margin for LexaGene Holdings Inc. (0V43)
Operating Margin as of 2026 TTM: 0.00%
According to LexaGene Holdings Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for LexaGene Holdings Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.